Understanding how certain RNA structures help start protein production

IRES-mediated translation: mechanisms and applications in mRNA therapeutics

NIH-funded research Univ of Massachusetts Med Sch Worcester · NIH-11128537

This study is looking at how certain RNA structures help start the process of making proteins, which is important for understanding how we can improve treatments for cancer, so patients might get better therapies in the future.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniv of Massachusetts Med Sch Worcester NIH-funded
Lab location1 site (Worcester, United States)
Project IDNIH-11128537 on NIH RePORTER

What this research studies

This research investigates the mechanisms by which specific RNA structures, known as internal ribosome entry sites (IRES), initiate protein synthesis. By using advanced techniques like cryo-electron microscopy, the team aims to uncover how these structures change during the translation process and how mutations in these RNA sequences can affect their function. The goal is to enhance our understanding of RNA dynamics, which could lead to improved mRNA therapeutics, particularly in cancer treatment. Patients may benefit from insights that could lead to more effective anti-cancer therapies.

Who could benefit from this research

Good fit: Ideal candidates for this research are patients with cancers that may be treated with innovative mRNA therapeutics.

Not a fit: Patients with conditions unrelated to mRNA therapeutics or those not eligible for experimental treatments may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to the development of more effective mRNA-based therapies for cancer and other diseases.

How similar studies have performed: Previous research has shown promise in using RNA structures for therapeutic applications, indicating potential for success in this area.

Where this research is happening

Worcester, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions anti-cancer immunotherapyanticancer immunotherapycancer immunotherapyCommunicable Diseases
Last reviewed 2026-06-09 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.